A Prospective Phase 3 Multi-center Study to Assess the Efficacy and Safety of 18F-mFBG PET Imaging in Subjects with Neuroblastoma
Latest Information Update: 01 Apr 2025
At a glance
- Drugs 18F meta fluorobenzylguanidine (Primary)
- Indications Neuroblastoma
- Focus Diagnostic use; Registrational
- Sponsors Illumina Radiopharmaceuticals
Most Recent Events
- 07 Oct 2024 Status changed from active, no longer recruiting to completed.
- 09 Feb 2024 Planned End Date changed from 1 Jan 2024 to 1 May 2024.
- 09 Feb 2024 Status changed from recruiting to active, no longer recruiting.